楽天メディカル - がん克服。生きる。

Rakuten Medical Logo

画像提供:Rush University Medical Center

画像提供:Rush University Medical Center

Illuminox™

イルミノックス™プラットフォームとは、薬剤と光を組み合わせた、がんをはじめとした様々な疾患に対する新しい治療法を開発するための技術基盤です。
この技術は、米国国立がん研究所の小林久隆先生らが開発したがん光免疫療法が基になっています。

Letter from Our CEO

CEOレター

Letter from Our CEO

CEOレター

父の治療には、間に合わなかったが。

“父親を救いたい”ー。当時、叶わなかった願いは、
“世界中の患者さんを救いたい”という新たな決意となって、楽天メディカルに息づいています。

Our Mission

ミッション

私たちは、世界中のがんと共に生きる患者さんとそのご家族が、私たちのプラットフォームを介して、より良い治療にアクセスできるようになることで、一人でも多くの人々が、本当に生きたい人生を生きることができる社会の実現を目指します。

Mission

がん克服
国や、貧富の差に かかわらず、患者さんがより良いがん治療に アクセスできる 医療エコシステムを 構築

Vision

先駆的ながん治療法の開発・実用化に向けたイノベーションを創出し続けるグローバルカンパニーへ

Focus

イルミノックス™プラットフォームに基づくがん治療法を開発し、新たな標準治療として確立

 

お知らせ
弊社製品は医療用医薬品および医療機器ともに厚生労働省より製造販売承認を2020年9月に取得いたしました。
薬価公示後すみやかに患者さんにお届けできるよう発売の準備をすすめております。

 

People
×
Innovation
×
Action
×
A Note from Our Chairman

In 2012, my father was diagnosed with pancreatic cancer. I was ready to do anything for him to be cured. With that sole purpose, I read many scientific papers from all over the world, and I met and talked with numerous experts in the field. How could I cure my father’s cancer? I searched every single possibility available.

That is when I found out about photoimmunotherapy that was only at an early stage of research. Although I had many doubts about this completely new approach, desperate for a miracle, I immediately went to meet the researcher.

Everyone was still doubtful at that stage. But the more I heard about this research, the more it made sense. 

I instinctively thought, “This is it.” It was the same feeling I got as when I grasped that the internet would change the world forever. Somehow, wishing to save my father, I immediately made up my mind to support the research personally to speed it up.

Unfortunately, we didn’t make it in time to save my father. But I decided to continue my support. My father who was as an economist always said, “One important mission of corporations is to contribute to humanity.”

Left behind, I resolved to provide this latest treatment to as many people as possible. It will surely be a path fraught with difficulties. But right at this moment there are many who are suffering from cancer, many who wish to save the lives of their loved ones, and I know exactly how they feel.

To provide this treatment as soon as possible, to bring this treatment to as many people as possible, I will not fail to support this research from now on.

Chairman, Rakuten Medical, Inc.

Hiroshi Mikitani

×